Trial Profile
A 24-week, double-blind, randomized study to compare rimabotulinumtoxinB versus onabotulinumtoxinA in the treatment of masseter hypertrophy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum toxin B (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Hypertrophy
- Focus Therapeutic Use
- Acronyms Split-Face
- 02 Dec 2015 New trial record